From Lieff Cabraser, "One of the nation's premier
plaintiffs' firms" — The American Lawyer
Bayer AG reported a drop in annual earnings for the year 2012 due to having to reserve an additional $1.5 billion to cover Yaz and Yasmin litigation expenses, stated Thomson Reuters.
Read the full story »
Bayer AG reported a drop in annual earnings for the year 2012 due to having to reserve an additional $1.5 billion to cover Yaz and Yasmin litigation expenses, stated Thomson Reuters. Read the full story »
The European Medicines Agency (EMA) will meet in February 2013 to review the adverse side effects associated with third- and fourth-generation hormonal birth control pills such as Yaz.
As reported by Fox News, a new study, presented at the American Academy of Neurology’s 65th Annual Meeting in San Diego this week, found that taking contraceptives significantly increased the risks of blood clots, or …
Bayer has settled nearly 1,500 cases in which women who took the birth control drugs Yaz and Yasmin and developed blood clots.
Bayer, the manufacturer of the prescription medicines Yaz, Yasmin and Ocella has reached settlements, according to a Bloomberg news report, totaling over $400 million in lawsuits alleging that these birth control drugs caused blood …
In this July 2012 video update, Yaz injury lawyer Wendy Fleishman explains that Bayer has settled nearly 1,500 cases where women who took Yaz, Yasmin, and Ocella developed blood clots. More specifically, the cases Bayer …
In December 2011, Judge David Herndon of the U.S. District Court for the Southern District of Illinois ordered a delay in the first women’s Yaz injuries bellwether trial. Since then, Bayer has settled over 600 …
Bloomberg reports that Bayer, the German drug manufacturer responsible for producing Yaz and other dropsirenone-containing birth control pills, will pay at least $110 million to settle approximately 500 personal injury lawsuits over blood clot complications.
The Food and Drug Administration announced today that that newer generation birth control pills, including Bayer’s Yaz and Yasmin, which contain the hormone drospirenone may be associated with a higher risk of blood clots, and …
Lieff Cabraser attorney Wendy Fleishman provides an update on Yaz, Yasmin & Ocella blood clot injuries and lawsuits.
Yesterday, the Project on Government Oversight (POGO), an independent, non-partisan investigative organization, sent a letter to FDA Commissioner Margaret Hamburg detailing the multiple conflicts of interest among certain members of the recent FDA advisory committee that …
Attorney Paulina do Amaral Provides a Jan. 2013 Update on the Yaz, Yasmin and Ocella Blood Clot Injury Litigation
Attorney Wendy Fleishman Provides a July 2012 Update on the Yaz, Yasmin, & Ocella blood clot injury litigation
